217 related articles for article (PubMed ID: 30182170)
1. Characteristics of methotrexate-induced stroke-like neurotoxicity.
Watanabe K; Arakawa Y; Oguma E; Uehara T; Yanagi M; Oyama C; Ikeda Y; Sasaki K; Isobe K; Mori M; Hanada R; Koh K
Int J Hematol; 2018 Dec; 108(6):630-636. PubMed ID: 30182170
[TBL] [Abstract][Full Text] [Related]
2. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J
Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947
[TBL] [Abstract][Full Text] [Related]
3. [Acute methotrexate-related neurotoxicity and pseudo-stroke syndrome].
Deneux V; Leboucq N; Saumet L; Haouy S; Akbaraly T; Sirvent N
Arch Pediatr; 2017 Dec; 24(12):1244-1248. PubMed ID: 29146215
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
5. Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke.
Agarwal A; Vijay K; Thamburaj K; Ouyang T
Emerg Radiol; 2011 Aug; 18(4):345-7. PubMed ID: 21243392
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
Vagace JM; Caceres-Marzal C; Jimenez M; Casado MS; de Murillo SG; Gervasini G
Am J Hematol; 2011 Jan; 86(1):98-101. PubMed ID: 21064136
[TBL] [Abstract][Full Text] [Related]
7. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.
Inaba H; Khan RB; Laningham FH; Crews KR; Pui CH; Daw NC
Ann Oncol; 2008 Jan; 19(1):178-84. PubMed ID: 17947226
[TBL] [Abstract][Full Text] [Related]
8. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
[TBL] [Abstract][Full Text] [Related]
9. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome.
Rollins N; Winick N; Bash R; Booth T
AJNR Am J Neuroradiol; 2004; 25(10):1688-95. PubMed ID: 15569732
[TBL] [Abstract][Full Text] [Related]
10. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
[TBL] [Abstract][Full Text] [Related]
11. Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.
Tsujimoto S; Yanagimachi M; Tanoshima R; Urayama KY; Tanaka F; Aida N; Goto H; Ito S
Pediatr Blood Cancer; 2016 Nov; 63(11):1983-9. PubMed ID: 27399166
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.
Haykin ME; Gorman M; van Hoff J; Fulbright RK; Baehring JM
J Neurooncol; 2006 Jan; 76(2):153-7. PubMed ID: 16411025
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.
Haykin M; Gorman M; van Hoff J; Fulbright R; Baehring J
J Neurooncol; 2006 Jan; 76(2):153-7. PubMed ID: 16132495
[TBL] [Abstract][Full Text] [Related]
14. [Neurotoxicity during induction treatment of childhood acute lymphoblastic leukaemia--two case reports].
Kostić G; Jovancić D; Saranac L; Bjelaković B
Srp Arh Celok Lek; 2009; 137(5-6):266-70. PubMed ID: 19594068
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
[TBL] [Abstract][Full Text] [Related]
16. Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies.
Badke C; Fleming A; Iqbal A; Khilji O; Parhas S; Weinstein J; Morgan E; Hijiya N
Pediatr Blood Cancer; 2016 Apr; 63(4):723-6. PubMed ID: 26681571
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-induced acute toxic leukoencephalopathy.
Salkade PR; Lim TA
J Cancer Res Ther; 2012; 8(2):292-6. PubMed ID: 22842379
[TBL] [Abstract][Full Text] [Related]
18. Dextromethorphan Administration on Day 0 and Day 7 for Secondary Prevention of Methotrexate-induced Neurotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Case Series.
Fustino NJ; Juhl K; Leister J
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e284-e287. PubMed ID: 31929386
[TBL] [Abstract][Full Text] [Related]
19. A Stroke Mimic: Methotrexate-induced Neurotoxicity in the Emergency Department.
Rogers P; Pan WJ; Drachtman RA; Haines C
J Emerg Med; 2017 Apr; 52(4):559-561. PubMed ID: 28094079
[TBL] [Abstract][Full Text] [Related]
20. Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings.
Brugnoletti F; Morris EB; Laningham FH; Patay Z; Pauley JL; Pui CH; Jeha S; Inaba H
Pediatr Blood Cancer; 2009 Feb; 52(2):293-5. PubMed ID: 18831032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
